臨牀消化器内科 Vol.21 No.2(5-1)


特集名 膵管内乳頭粘液性腫瘍 (IPMT ; intraductal papillary-mucinous tumor)
題名 治療 (1) 治療方針の決定
発刊年月 2006年 02月
著者 長川 達哉 札幌厚生病院消化器内科
著者 須賀 俊博 札幌厚生病院消化器内科
著者 村岡 俊二 札幌厚生病院臨床病理科
【 要旨 】 IPMTの治療方針として重要なポイントは手術適応症例の選択である.IPMTは高齢者に発生し,多くの症例が緩徐に進展する性質を有していることから生命予後を考慮し,腺腫以上の病変を積極的に切除する方針から,浸潤癌を逃さず切除する治療方針に変化しつつある.浸潤癌の予後は非浸潤癌に比して非常に悪く,膵管壁を破壊する充実性腫瘤像を認めた場合は絶対的手術適応である.主膵管型IPMTは生物学的悪性度が高く,原則的に手術適応とする.分枝型IPMTについては結節状隆起高を指標とした基準と,拡張分枝径と主膵管径の組み合わせによる手術適応の基準があり,後者の妥当性については今後も検討が必要である.これらの基準を満たさない分枝型IPMTの症例は過形成病変と考え,経過観察とするが,IPMTの異時性多発や他臓器の悪性腫瘍の合併にも留意した経過観察が必要である.
Theme IPMT ; Intraductal Papillary-Mucinous Tumor
Title Therapeutic Strategy for Intraductal Papillary-Mucinous Tumors
Author Tatsuya Nagakawa Department of Gastroenterology, Sapporo Kohsei Hospital
Author Toshihiro Suga Department of Gastroenterology, Sapporo Kohsei Hospital
Author Syunji Muraoka Department of Clinical Pathology, Sapporo Kohsei Hospital
[ Summary ] IPMT (intraductal papillary-mucinous tumors) of the pancreas are now known to be common cystic neoplasms, often found in eldery people. Most exhibit a slow growing nature. In the therapeutic strategy for IPMT, it is most important to select the appropriate cases for surgical resection. Formerly, all of the lesions suspected of being intraductal papillary-mucinous adenomas (IPMA) and intraductal papillary-mucinous adenocarcinomas (IPMC) were candidates for this operation. However, now it is thought resected cases should be limited to advanced lesions suspected to be IPMC and invasive cancer originating from IPMC. In this paper, we discussed the criteria for surgical approaches based on our experience and published papers. IPMT is divided into two types according to the location of mural nodules and biological behavior. Since the main pancreatic duct type IPMT has clear malignant potential, all of these cases should be resected. On the other hand, the branch duct type IPMT shows a wide spectrum of histological characteristics, including non-neoplastic lesions (namely hyperplasia), IPMA and IPMC. Therefore we need to employ complex criteria, including the height of mural nodules, the maximum size of dilated branches and the diameter of the main pancreatic ducts to distinguish hyperplastic lesions from other neoplasms. Concerning clinical follow ups for IPMT, we should pay attention to metachronous multifocal lesions in the pancreas and other malignancies for long term surveillance.
戻る